Shackleton buys NESTA stake in healthcare company

Shackleton Ventures has deviated from its typical direct secondaries strategy, making a follow-on investment into medical technology company Nanosight. It purchased the stake from UK government-backed NESTA, which hopes the deal will set a precedent for early stage secondaries investments.